Dr. Sing-Young Chen is a postdoctoral researcher at the JDRF Centre of Excellence at the University of British Columbia, and the second annual recipient of a J. Andrew McKee Fellowship […]
Results are out: TZIELD (teplizumab) benefits individuals newly diagnosed with type 1 diabetes
In a coordinated release of information today, Dr. Kevan Herold (Yale University) presented the PROTECT clinical trial results at the International Society for Paediatric and Adolescent Diabetes (ISPAD) conference simultaneous […]
Building capacity for the future of type 1 diabetes research
Training the next generation of researchers and clinicians in type 1 diabetes (T1D) is a central goal of JDRF’s global research strategy. Support of these emerging leaders is essential to […]
Ontario life sciences startup, Allarta, receives award from JDRF International to advance its work in creating a functional cure for type 1 diabetes
Hamilton, ON, Canada and New York, NY – On October 3, 2023, Allarta Life Science, a Hamilton, Ontario-based regenerative medicine company announced it has received an award from JDRF International […]
Study Suggests Semaglutide Increases Insulin Production in Newly Diagnosed People with Type 1 Diabetes
Semaglutide, brand names Ozempic®, Rybelsus®, and Wegovy®, is all over the news. It is Health Canada-approved to help people with type 2 diabetes (T2D) manage their blood glucose levels. It […]
New JDRF Canada Emerging Clinician Research Award (ECRA) awarded to Dr. Alanna Weisman
The JDRF Canada Emerging Clinician Research Award (ECRA) is designed to provide crucial support to investigators who plan to pursue a career in type 1 diabetes (T1D)-related clinical investigation. Awards […]
$100M Campaign to Accelerate: A Labour of Love to Defeat the T1D Monster
The following is a guest blog by Ryan MacDonald, volunteer co-chair of JDRF Canada’s $100M Campaign to Accelerate – JDRF’s bold fundraising campaign to raise $100M by 2025 to accelerate […]
Warrior Hill – a new apparel company with athletic clothing designed for people with type 1 diabetes
50% of profits go to JDRF Warrior Hill was founded by a family with both a parent and child who live with type 1 diabetes (T1D) who have a passion […]
Nasal versus Injectable Glucagon for Children with T1D
Content repurposed with permission from: type1better.com Despite best efforts to keep a child’s blood glucose within target, severe hypoglycemic episodes can happen, and it’s best to be prepared for the unpredictable. The […]
New developments in islet cell therapies for type 1 diabetes
A significant part of JDRF Canada funding goes towards supporting cure-based research for type 1 diabetes (T1D). One such pathway is via stem cell replacement therapies that replace the beta […]
Celebrating 30 years of the Sun Life Walk Cure to Diabetes for JDRF
Throughout June more than 40 communities gathered across Canada to raise funds for type 1 diabetes research. The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising […]
CGM Use in Pregnancy
A 2013-2016 JDRF-funded study showed that the use of a continuous glucose monitor (CGM) during pregnancy for people with type 1 diabetes (T1D) results in healthier pregnancies and babies. The […]